Literature DB >> 22484813

Cooperation between Rb and Arf in suppressing mouse retinoblastoma.

Karina Conkrite1, Maggie Sundby, David Mu, Shizuo Mukai, David MacPherson.   

Abstract

Retinoblastoma is a pediatric cancer that has served as a paradigm for tumor suppressor gene function. Retinoblastoma is initiated by RB gene mutations, but the subsequent cooperating mutational events leading to tumorigenesis are poorly characterized. We investigated what these additional genomic alterations might be using human retinoblastoma samples and mouse models. Array-based comparative genomic hybridization studies revealed deletions in the CDKN2A locus that include ARF and P16INK4A, both of which encode tumor suppressor proteins, in both human and mouse retinoblastoma. Through mouse genetic analyses, we found that Arf was the critical tumor suppressor gene in the deleted region. In mice, inactivation of one allele of Arf cooperated with Rb and p107 loss to rapidly accelerate retinoblastoma, with frequent loss of heterozygosity (LOH) at the Arf locus. Arf has been reported to exhibit p53-independent tumor suppressor roles in other systems; however, our results showed no additive effect of p53 and Arf coinactivation in promoting retinoblastoma. Moreover, p53 inactivation completely eliminated any selection for Arf LOH. Thus, our data reveal important insights into the p53 pathway in retinoblastoma and show that Arf is a key collaborator with Rb in retinoblastoma suppression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22484813      PMCID: PMC3336990          DOI: 10.1172/JCI61403

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  Pax6 is required for the multipotent state of retinal progenitor cells.

Authors:  T Marquardt; R Ashery-Padan; N Andrejewski; R Scardigli; F Guillemot; P Gruss
Journal:  Cell       Date:  2001-04-06       Impact factor: 41.582

Review 2.  Divorcing ARF and p53: an unsettled case.

Authors:  Charles J Sherr
Journal:  Nat Rev Cancer       Date:  2006-08-17       Impact factor: 60.716

3.  p14ARF links the tumour suppressors RB and p53.

Authors:  S Bates; A C Phillips; P A Clark; F Stott; G Peters; R L Ludwig; K H Vousden
Journal:  Nature       Date:  1998-09-10       Impact factor: 49.962

4.  Impaired expression and promotor hypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues.

Authors:  Kwong Wai Choy; Chi Pui Pang; Ka Fai To; Christopher B O Yu; Joan S K Ng; Dennis S C Lam
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-05       Impact factor: 4.799

5.  Inactivation of the p53 pathway in retinoblastoma.

Authors:  Nikia A Laurie; Stacy L Donovan; Chie-Schin Shih; Jiakun Zhang; Nicholas Mills; Christine Fuller; Amina Teunisse; Suzanne Lam; Yolande Ramos; Adithi Mohan; Dianna Johnson; Matthew Wilson; Carlos Rodriguez-Galindo; Micaela Quarto; Sarah Francoz; Susan M Mendrysa; R Kiplin Guy; Jean-Christophe Marine; Aart G Jochemsen; Michael A Dyer
Journal:  Nature       Date:  2006-11-02       Impact factor: 49.962

6.  Mouse genomic representational oligonucleotide microarray analysis: detection of copy number variations in normal and tumor specimens.

Authors:  B Lakshmi; Ira M Hall; Christopher Egan; Joan Alexander; Anthony Leotta; John Healy; Lars Zender; Mona S Spector; Wen Xue; Scott W Lowe; Michael Wigler; Robert Lucito
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-14       Impact factor: 11.205

7.  Loss of heterozygosity on chromosome 17 and mutation of the p53 gene in retinoblastoma.

Authors:  M V Kato; T Shimizu; K Ishizaki; A Kaneko; D W Yandell; J Toguchida; M S Sasaki
Journal:  Cancer Lett       Date:  1996-08-23       Impact factor: 8.679

8.  Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.

Authors:  Aaron Aslanian; Phillip J Iaquinta; Raluca Verona; Jacqueline A Lees
Journal:  Genes Dev       Date:  2004-06-02       Impact factor: 11.361

Review 9.  The senescence-associated secretory phenotype: the dark side of tumor suppression.

Authors:  Jean-Philippe Coppé; Pierre-Yves Desprez; Ana Krtolica; Judith Campisi
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

10.  Expression of arf tumor suppressor in spermatogonia facilitates meiotic progression in male germ cells.

Authors:  Michelle L Churchman; Ignasi Roig; Maria Jasin; Scott Keeney; Charles J Sherr
Journal:  PLoS Genet       Date:  2011-07-21       Impact factor: 5.917

View more
  15 in total

Review 1.  The retinoblastoma tumor suppressor and stem cell biology.

Authors:  Julien Sage
Journal:  Genes Dev       Date:  2012-07-01       Impact factor: 11.361

2.  E2f2 induces cone photoreceptor apoptosis independent of E2f1 and E2f3.

Authors:  D Chen; Y Chen; D Forrest; R Bremner
Journal:  Cell Death Differ       Date:  2013-04-05       Impact factor: 15.828

3.  Cancer: The origin of human retinoblastoma.

Authors:  Rod Bremner; Julien Sage
Journal:  Nature       Date:  2014-09-24       Impact factor: 49.962

4.  Identification of microRNA-mRNA regulatory networks and pathways related to retinoblastoma across human and mouse.

Authors:  Rui Tian; He Zou; Lu-Fei Wang; Mei-Jiao Song; Lu Liu; Hui Zhang
Journal:  Int J Ophthalmol       Date:  2020-04-18       Impact factor: 1.779

5.  Whole chromosome instability resulting from the synergistic effects of pRB and p53 inactivation.

Authors:  A L Manning; C Benes; N J Dyson
Journal:  Oncogene       Date:  2013-06-24       Impact factor: 9.867

6.  A mouse model of MYCN-driven retinoblastoma reveals MYCN-independent tumor reemergence.

Authors:  Nan Wu; Deshui Jia; Breanna Bates; Ryan Basom; Charles G Eberhart; David MacPherson
Journal:  J Clin Invest       Date:  2017-02-06       Impact factor: 14.808

Review 7.  Apoptotic and autophagic pathways with relevant small-molecule compounds, in cancer stem cells.

Authors:  Lan Zhang; Xupeng Tong; Jingjing Li; Yue Huang; Xinyue Hu; Yi Chen; Jian Huang; Jinhui Wang; Bo Liu
Journal:  Cell Prolif       Date:  2015-05-25       Impact factor: 6.831

8.  Synthetic lethality between Rb, p53 and Dicer or miR-17-92 in retinal progenitors suppresses retinoblastoma formation.

Authors:  David Nittner; Irina Lambertz; Frederic Clermont; Pieter Mestdagh; Corinna Köhler; Søren Jensby Nielsen; Aart Jochemsen; Frank Speleman; Jo Vandesompele; Michael A Dyer; Alexander Schramm; Johannes H Schulte; Jean-Christophe Marine
Journal:  Nat Cell Biol       Date:  2012-08-05       Impact factor: 28.824

Review 9.  Overview of recurrent chromosomal losses in retinoblastoma detected by low coverage next generation sequencing.

Authors:  A J García-Chequer; A Méndez-Tenorio; G Olguín-Ruiz; C Sánchez-Vallejo; P Isa; C F Arias; J Torres; A Hernández-Angeles; M A Ramírez-Ortiz; C Lara; M L Cabrera-Muñoz; S Sadowinski-Pine; J C Bravo-Ortiz; G Ramón-García; J Diegopérez-Ramírez; G Ramírez-Reyes; R Casarrubias-Islas; J Ramírez; M A Orjuela; M V Ponce-Castañeda
Journal:  Cancer Genet       Date:  2015-12-15

10.  Retinoblastoma tumor cell proliferation is negatively associated with an immune gene expression signature and increased immune cells.

Authors:  Aaron L Sarver; Chencheng Xie; Megan J Riddle; Colleen L Forster; Xiaohong Wang; Huarui Lu; Wyatt Wagner; Jakub Tolar; Timothy C Hallstrom
Journal:  Lab Invest       Date:  2021-03-03       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.